- Home
- MYNZ vs EKSO Comparison
MYNZ vs EKSO Comparison
Compare MYNZ & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYNZ
- EKSO
- Stock Information
- Founded
- MYNZ 2021
- EKSO 2005
- Country
- MYNZ Germany
- EKSO United States
- Employees
- MYNZ N/A
- EKSO N/A
- Industry
- MYNZ Biotechnology: Pharmaceutical Preparations
- EKSO Medical/Dental Instruments
- Sector
- MYNZ Health Care
- EKSO Health Care
- Exchange
- MYNZ Nasdaq
- EKSO Nasdaq
- Market Cap
- MYNZ 16.0M
- EKSO 13.4M
- IPO Year
- MYNZ 2021
- EKSO N/A
- Fundamental
- Price
- MYNZ $5.74
- EKSO $0.55
- Analyst Decision
- MYNZ Buy
- EKSO Strong Buy
- Analyst Count
- MYNZ 3
- EKSO 2
- Target Price
- MYNZ $14.00
- EKSO $5.50
- AVG Volume (30 Days)
- MYNZ 361.6K
- EKSO 318.5K
- Earning Date
- MYNZ 04-15-2025
- EKSO 03-03-2025
- Dividend Yield
- MYNZ N/A
- EKSO N/A
- EPS Growth
- MYNZ N/A
- EKSO N/A
- EPS
- MYNZ N/A
- EKSO N/A
- Revenue
- MYNZ $917,203.00
- EKSO $17,682,000.00
- Revenue This Year
- MYNZ $21.95
- EKSO N/A
- Revenue Next Year
- MYNZ $30.77
- EKSO $32.74
- P/E Ratio
- MYNZ N/A
- EKSO N/A
- Revenue Growth
- MYNZ 16.23
- EKSO 4.12
- 52 Week Low
- MYNZ $0.18
- EKSO $0.47
- 52 Week High
- MYNZ $8.20
- EKSO $2.16
- Technical
- Relative Strength Index (RSI)
- MYNZ 48.77
- EKSO 42.05
- Support Level
- MYNZ $5.08
- EKSO $0.50
- Resistance Level
- MYNZ $8.16
- EKSO $0.61
- Average True Range (ATR)
- MYNZ 1.10
- EKSO 0.04
- MACD
- MYNZ -0.23
- EKSO 0.00
- Stochastic Oscillator
- MYNZ 21.15
- EKSO 57.33
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are EksoHealth and EksoWorks. All of the company's operations are held in the United States. The EksoHealth segment which derives majority revenue designs, engineers, manufactures and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The regions company operates in are the Americas, EMEA, and APAC.